美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Crescent Biopharma Inc

10.98

+0.19001.76%

盘后：10.67-0.3100-2.82%17:30 EST

成交量：7.36万

成交额：79.89万

市值：1.53亿

市盈率：-0.50

高：11.00

开：11.00

低：10.62

收：10.79

52周最高：37.00

52周最低：9.81

股本：1,389.25万

流通股本：461.21万

量比：0.71

换手率：1.60%

股息：- -

股息率：- -

每股收益(TTM):-21.9706

每股收益(LYR):-3.3635

净资产收益率：-182.66%

总资产收益率：-73.99%

市净率：2.10

市盈率(LYR):-3.26

数据加载中...

总览公司新闻资讯公告

Crescent Biopharma 宣布其PD-1/VEGF双特异性抗体CR-001及靶向ITGB6的ADC药物CR-003新药临床试验申请获监管批准，用于治疗实体瘤

新闻稿：Crescent Biopharma公布诱导奖励授予情况

BUZZ--美国股票走势-雷蒙德-詹姆斯、CAVA、派拉蒙天空之舞

BUZZ--美国股票走势-雷蒙德-詹姆斯、CAVA、派拉蒙天空之舞

BUZZ--美国股票走势-Meta、GE Vernova、Kroger

BUZZ--美国股票走势-Meta、GE Vernova、Kroger

BUZZ-新月生物制药公司在合作开发抗癌药物后业绩大增

Crescent Biopharma 宣布与 Kelun-Biotech 达成重大合作，并进行 1.85 亿美元私人配售，推动和扩展全球下一代实体肿瘤治疗药物的管道

Crescent Biopharma Inc - 将获得2000万美元的预付款，以及来自科伦博泰生物的最高3000万美元的额外里程碑款项

Crescent Biopharma Inc - 科伦博泰生物-B将获得8000万美元的预付款，以及来自Crescent的最高达12.5亿美元的额外里程碑付款

科伦药业与Crescent Biopharma达成战略合作，共同开发及商业化新型抗肿瘤疗法

Crescent Biopharma：截至9月30日现金为1.333亿美元，预计可支持运营至2027年

凯赛生物拟推2025年员工持股计划

智通财经网

凯赛生物授权子公司互保，额度不超20亿

新月生物制药公司公布截至 6 月 30 日的季度业绩 - 收益摘要

凯赛生物：累计回购23万股

复利研究院点评凯赛生物：如果合成生物是未来的石油，凯赛能否成为它的中石化？

68倍PE，凯赛生物值不值？

从业绩和技术看凯赛生物的行业定位：“合成生物第一股”是怎么炼成的？

新月生物制药提交实益所有权初始声明首席科学官简·平卡斯为申报人

华尔街洞察

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/CBIO/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CBIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBIO\",,,,,undefined,":{"symbol":"CBIO","market":"US","secType":"STK","nameCN":"Crescent Biopharma Inc","latestPrice":10.98,"timestamp":1768251600000,"preClose":10.79,"halted":0,"volume":73593,"hourTrading":{"tag":"盘后","latestPrice":10.67,"preClose":10.98,"latestTime":"17:30 EST","volume":505,"amount":5530.449677500001,"timestamp":1768257029925},"delay":0,"floatShares":4612100,"shares":13892516,"eps":-21.9706,"marketStatus":"盘后交易","change":0.19,"latestTime":"01-12 19:47:29 EST","open":11,"high":11,"low":10.62,"amount":798888.369942,"amplitude":0.035218,"askPrice":13.56,"askSize":100,"bidPrice":10.26,"bidSize":25,"shortable":3,"etf":0,"ttmEps":-21.9706,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1768266000000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1389330000000,"exchange":"NASDAQ","adjPreClose":10.79,"preHourTrading":{"tag":"盘前","latestPrice":11.01,"preClose":10.79,"latestTime":"09:29 EST","volume":4968,"amount":54808.029215999995,"timestamp":1768228199999},"postHourTrading":{"tag":"盘后","latestPrice":10.67,"preClose":10.98,"latestTime":"17:30 EST","volume":505,"amount":5530.449677500001,"timestamp":1768257029925},"volumeRatio":0.712444,"impliedVol":2.2495,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CBIO\",,,,,undefined,":{"symbol":"CBIO","floatShares":4612100,"roa":"-73.99%","roe":"-182.66%","lyrEps":-3.363532,"volumeRatio":0.712444,"shares":13892516,"dividePrice":0,"high":11,"amplitude":0.035218,"preClose":10.79,"low":10.62,"week52Low":9.81,"pbRate":"2.10","week52High":37,"institutionHeld":0.0724,"latestPrice":10.98,"committee":-0.6,"eps":-21.9706,"divideRate":0,"volume":73593,"delay":0,"ttmEps":-21.9706,"open":11,"prevYearClose":11.86,"prevWeekClose":10.79,"prevMonthClose":11.86,"prevQuarterClose":11.86,"fiveDayClose":11.11,"twentyDayClose":15.31,"sixtyDayClose":11.29},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"CBIO","fiscalQuarterEnding":"2025/09","expectedEps":-1.01,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.27},{"market":"US","date":"2025-07-31","symbol":"CBIO","fiscalQuarterEnding":"2025/06","expectedEps":-2.69,"name":null,"time":"","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"","actualEps":-4.93},{"market":"US","date":"2025-06-16","symbol":"CBIO","type":"split","dateTimestamp":1750046400000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CBIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":7,"updateTime":1756184400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CBIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CBIO","date":"2026-01-09","current":-0.499759,"percent":0.194647,"low":-7.394562,"twenty":-2.947456,"median":-0.984999,"eighty":-0.169604,"high":2.563796,"avg":-1.295144,"sd":1.951066,"marketCap":214459528},"quantilePoints":[{"date":"2021-01-15","current":-2.832498,"twenty":-4.333629,"median":-2.228683,"eighty":-1.204263,"marketCap":144298764},{"date":"2021-01-22","current":-2.975641,"twenty":-4.324881,"median":-2.230636,"eighty":-1.204495,"marketCap":151591045},{"date":"2021-01-29","current":-3.415666,"twenty":-4.320134,"median":-2.232622,"eighty":-1.205581,"marketCap":174007683},{"date":"2021-02-05","current":-3.548665,"twenty":-4.311792,"median":-2.242584,"eighty":-1.207916,"marketCap":180783203},{"date":"2021-02-12","current":-4.114221,"twenty":-4.289913,"median":-2.245648,"eighty":-1.20987,"marketCap":209594894},{"date":"2021-02-19","current":-4.19405,"twenty":-4.29712,"median":-2.254824,"eighty":-1.210197,"marketCap":213661660},{"date":"2021-02-26","current":-3.702799,"twenty":-4.278552,"median":-2.260422,"eighty":-1.211192,"marketCap":188635404},{"date":"2021-03-05","current":-3.169815,"twenty":-4.272471,"median":-2.275971,"eighty":-1.213061,"marketCap":178273543},{"date":"2021-03-12","current":-3.426074,"twenty":-4.272037,"median":-2.280515,"eighty":-1.214161,"marketCap":192685816},{"date":"2021-03-19","current":-3.175385,"twenty":-4.272037,"median":-2.280515,"eighty":-1.214161,"marketCap":178586853},{"date":"2021-03-26","current":-2.868989,"twenty":-4.27182,"median":-2.284285,"eighty":-1.214711,"marketCap":161354789},{"date":"2021-04-01","current":-2.969264,"twenty":-4.27182,"median":-2.284285,"eighty":-1.214711,"marketCap":166994373},{"date":"2021-04-09","current":-2.846705,"twenty":-4.272037,"median":-2.280515,"eighty":-1.214161,"marketCap":160101547},{"date":"2021-04-16","current":-2.640584,"twenty":-4.272037,"median":-2.280515,"eighty":-1.214161,"marketCap":148509067},{"date":"2021-04-23","current":-2.846705,"twenty":-4.272037,"median":-2.280515,"eighty":-1.214161,"marketCap":160101547},{"date":"2021-04-30","current":-2.809386,"twenty":-4.27182,"median":-2.284285,"eighty":-1.214711,"marketCap":158002689},{"date":"2021-05-07","current":-1.894612,"twenty":-4.27182,"median":-2.284285,"eighty":-1.214711,"marketCap":141387327},{"date":"2021-05-14","current":-1.755982,"twenty":-4.27182,"median":-2.284285,"eighty":-1.214711,"marketCap":131041913},{"date":"2021-05-21","current":-1.785388,"twenty":-4.27182,"median":-2.284285,"eighty":-1.214711,"marketCap":133236395},{"date":"2021-05-28","current":-1.79379,"twenty":-4.27182,"median":-2.275197,"eighty":-1.214711,"marketCap":133863389},{"date":"2021-06-04","current":-1.764384,"twenty":-4.27182,"median":-2.260422,"eighty":-1.214711,"marketCap":131668908},{"date":"2021-06-11","current":-1.890411,"twenty":-4.27182,"median":-2.245648,"eighty":-1.214711,"marketCap":141073830},{"date":"2021-06-18","current":-1.818996,"twenty":-4.27182,"median":-2.233317,"eighty":-1.214711,"marketCap":135744374},{"date":"2021-06-25","current":-1.907215,"twenty":-4.271603,"median":-2.231282,"eighty":-1.215261,"marketCap":142327819},{"date":"2021-07-02","current":-1.823197,"twenty":-4.271603,"median":-2.228811,"eighty":-1.215261,"marketCap":136057871},{"date":"2021-07-09","current":-1.84,"twenty":-4.271603,"median":-2.228211,"eighty":-1.215261,"marketCap":137311861},{"date":"2021-07-16","current":-1.835799,"twenty":-4.271603,"median":-2.228211,"eighty":-1.215261,"marketCap":136998363},{"date":"2021-07-23","current":-1.810594,"twenty":-4.271603,"median":-2.228211,"eighty":-1.215261,"marketCap":135117379},{"date":"2021-07-30","current":-1.709772,"twenty":-4.271603,"median":-2.226846,"eighty":-1.215261,"marketCap":127593441},{"date":"2021-08-06","current":-1.773059,"twenty":-4.271603,"median":-2.218203,"eighty":-1.215261,"marketCap":137068113},{"date":"2021-08-13","current":-1.663511,"twenty":-4.271603,"median":-2.209087,"eighty":-1.215261,"marketCap":128599374},{"date":"2021-08-20","current":-1.594536,"twenty":-4.271603,"median":-2.209087,"eighty":-1.215261,"marketCap":123267204},{"date":"2021-08-27","current":-1.890722,"twenty":-4.271603,"median":-2.209087,"eighty":-1.215261,"marketCap":146164166},{"date":"2021-09-03","current":-1.821747,"twenty":-4.26328,"median":-2.208025,"eighty":-1.2153,"marketCap":140831997},{"date":"2021-09-10","current":-1.886665,"twenty":-4.26328,"median":-2.208025,"eighty":-1.2153,"marketCap":145850509},{"date":"2021-09-17","current":-2.101704,"twenty":-4.26328,"median":-2.208025,"eighty":-1.2153,"marketCap":162474331},{"date":"2021-09-24","current":-1.923181,"twenty":-4.26328,"median":-2.208025,"eighty":-1.2153,"marketCap":148673422},{"date":"2021-10-01","current":-1.647282,"twenty":-4.26328,"median":-2.208025,"eighty":-1.2153,"marketCap":127344746},{"date":"2021-10-08","current":-1.562077,"twenty":-4.254957,"median":-2.206531,"eighty":-1.215339,"marketCap":120757948},{"date":"2021-10-15","current":-1.622937,"twenty":-4.254957,"median":-2.206531,"eighty":-1.215339,"marketCap":125462804},{"date":"2021-10-22","current":-1.407898,"twenty":-4.254957,"median":-2.206531,"eighty":-1.215339,"marketCap":108838982},{"date":"2021-10-29","current":-1.334866,"twenty":-4.254957,"median":-2.206531,"eighty":-1.217573,"marketCap":103193156},{"date":"2021-11-05","current":-1.253719,"twenty":-4.254957,"median":-2.206531,"eighty":-1.230021,"marketCap":96920016},{"date":"2021-11-12","current":-0.620853,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":53710598},{"date":"2021-11-19","current":-0.475624,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":41146716},{"date":"2021-11-26","current":-0.45384,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":39262133},{"date":"2021-12-03","current":-0.395748,"twenty":-4.254957,"median":-2.206531,"eighty":-1.236189,"marketCap":34236580},{"date":"2021-12-10","current":-0.395748,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":34236580},{"date":"2021-12-17","current":-0.366703,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":31723804},{"date":"2021-12-23","current":-0.384856,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":33294289},{"date":"2021-12-31","current":-0.331848,"twenty":-4.246633,"median":-2.205037,"eighty":-1.233979,"marketCap":28708472},{"date":"2022-01-07","current":-0.303637,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":26267937},{"date":"2022-01-14","current":-0.284866,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":24644056},{"date":"2022-01-21","current":-0.232366,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20102212},{"date":"2022-01-28","current":-0.200125,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":17313030},{"date":"2022-02-04","current":-0.201832,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":17460656},{"date":"2022-02-11","current":-0.189306,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":16377021},{"date":"2022-02-18","current":-0.215955,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":18682493},{"date":"2022-02-25","current":-0.217371,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":18804991},{"date":"2022-03-04","current":-0.241552,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20896878},{"date":"2022-03-11","current":-0.236287,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20441437},{"date":"2022-03-18","current":-0.243403,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":21057067},{"date":"2022-03-25","current":-0.248813,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":21525072},{"date":"2022-04-01","current":-0.236294,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":20778002},{"date":"2022-04-08","current":-0.219111,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":19267104},{"date":"2022-04-14","current":-0.194197,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":17076301},{"date":"2022-04-22","current":-0.20762,"twenty":-4.23831,"median":-2.203543,"eighty":-1.231714,"marketCap":18256690},{"date":"2022-04-29","current":-0.171466,"twenty":-4.23831,"median":-2.203543,"eighty":-1.225062,"marketCap":15077508},{"date":"2022-05-06","current":-0.175797,"twenty":-4.23831,"median":-2.203543,"eighty":-1.212181,"marketCap":15458380},{"date":"2022-05-13","current":-0.141671,"twenty":-4.23831,"median":-2.203543,"eighty":-1.209147,"marketCap":11338034},{"date":"2022-05-20","current":-0.149458,"twenty":-4.23831,"median":-2.203543,"eighty":-1.209147,"marketCap":11961280},{"date":"2022-05-27","current":-0.483772,"twenty":-4.23831,"median":-2.203543,"eighty":-1.209147,"marketCap":38716775},{"date":"2022-06-03","current":-0.491638,"twenty":-4.23831,"median":-2.203543,"eighty":-1.206318,"marketCap":39346316},{"date":"2022-06-10","current":-0.538836,"twenty":-4.23831,"median":-2.203543,"eighty":-1.206318,"marketCap":43123562},{"date":"2022-06-17","current":-0.570301,"twenty":-4.23831,"median":-2.203543,"eighty":-1.204728,"marketCap":45641726},{"date":"2022-06-24","current":-0.593899,"twenty":-4.246633,"median":-2.205037,"eighty":-1.203969,"marketCap":47530350},{"date":"2022-07-01","current":-0.704026,"twenty":-4.246633,"median":-2.205037,"eighty":-1.190642,"marketCap":56343924},{"date":"2022-07-08","current":-0.711892,"twenty":-4.246633,"median":-2.205037,"eighty":-1.183449,"marketCap":56973465},{"date":"2022-07-15","current":-0.688294,"twenty":-4.246633,"median":-2.205037,"eighty":-1.17379,"marketCap":55084842},{"date":"2022-07-22","current":-0.688294,"twenty":-4.246633,"median":-2.205037,"eighty":-1.166615,"marketCap":55084842},{"date":"2022-07-29","current":-0.688294,"twenty":-4.246633,"median":-2.205037,"eighty":-1.164065,"marketCap":55084842},{"date":"2022-08-05","current":-0.735491,"twenty":-4.246633,"median":-2.205037,"eighty":-1.164065,"marketCap":58862089},{"date":"2022-08-12","current":-0.755157,"twenty":-4.246633,"median":-2.205037,"eighty":-1.164065,"marketCap":60435941},{"date":"2022-08-19","current":-7.394562,"twenty":-4.319663,"median":-2.219417,"eighty":-1.173236,"marketCap":62639335},{"date":"2022-08-26","current":-6.948659,"twenty":-4.374472,"median":-2.231928,"eighty":-1.186522,"marketCap":58862089},{"date":"2022-09-02","current":-7.245928,"twenty":-4.467447,"median":-2.249855,"eighty":-1.198454,"marketCap":61380253},{"date":"2022-09-09","current":-7.245928,"twenty":-4.558156,"median":-2.284285,"eighty":-1.205949,"marketCap":61380253},{"date":"2022-09-16","current":-7.283086,"twenty":-4.607295,"median":-2.335818,"eighty":-1.223882,"marketCap":61695023},{"date":"2022-09-23","current":-1.818542,"twenty":-4.702259,"median":-2.339886,"eighty":-1.237407,"marketCap":15404869},{"date":"2022-09-30","current":-1.872794,"twenty":-4.702259,"median":-2.339886,"eighty":-1.24606,"marketCap":15864434},{"date":"2022-10-07","current":-1.9891,"twenty":-4.702259,"median":-2.339886,"eighty":-1.250381,"marketCap":16849666},{"date":"2022-10-14","current":-2.235462,"twenty":-4.702259,"median":-2.339886,"eighty":-1.264627,"marketCap":18936595},{"date":"2022-10-21","current":-2.143308,"twenty":-4.702259,"median":-2.339886,"eighty":-1.287061,"marketCap":18155964},{"date":"2022-10-28","current":-2.158172,"twenty":-4.702259,"median":-2.339886,"eighty":-1.31186,"marketCap":18281872},{"date":"2022-11-04","current":-2.07345,"twenty":-4.702259,"median":-2.339886,"eighty":-1.333243,"marketCap":17564195},{"date":"2022-11-11","current":-2.064904,"twenty":-4.702259,"median":-2.339886,"eighty":-1.341215,"marketCap":17491798},{"date":"2022-11-18","current":1.47314,"twenty":-4.702259,"median":-2.339886,"eighty":-1.340298,"marketCap":17505320},{"date":"2022-11-25","current":1.457505,"twenty":-4.702259,"median":-2.339886,"eighty":-1.333243,"marketCap":17319529},{"date":"2022-12-02","current":1.457505,"twenty":-4.702259,"median":-2.339886,"eighty":-1.31186,"marketCap":17319529},{"date":"2022-12-09","current":1.350444,"twenty":-4.702259,"median":-2.339886,"eighty":-1.287061,"marketCap":16047331},{"date":"2022-12-16","current":1.319704,"twenty":-4.702259,"median":-2.33949,"eighty":-1.264627,"marketCap":15682046},{"date":"2022-12-23","current":1.332954,"twenty":-4.702259,"median":-2.284285,"eighty":-1.246705,"marketCap":15839496},{"date":"2022-12-30","current":1.397879,"twenty":-4.702259,"median":-2.249855,"eighty":-1.238056,"marketCap":16611002},{"date":"2023-01-06","current":2.033511,"twenty":-4.702259,"median":-2.235462,"eighty":-1.228022,"marketCap":24164207},{"date":"2023-01-13","current":0.834057,"twenty":-4.702259,"median":-2.228683,"eighty":-1.205599,"marketCap":9911100},{"date":"2023-01-20","current":0.847084,"twenty":-4.603457,"median":-2.215921,"eighty":-1.195389,"marketCap":10065902},{"date":"2023-01-27","current":0.937321,"twenty":-4.472686,"median":-2.202049,"eighty":-1.178581,"marketCap":11138189},{"date":"2023-02-03","current":0.926201,"twenty":-4.288569,"median":-2.18711,"eighty":-1.155134,"marketCap":11006041},{"date":"2023-02-10","current":0.79434,"twenty":-4.214316,"median":-2.168359,"eighty":-1.126768,"marketCap":9439143},{"date":"2023-02-17","current":0.798471,"twenty":-4.189559,"median":-2.158428,"eighty":-0.733918,"marketCap":9488227},{"date":"2023-02-24","current":0.76352,"twenty":-4.166469,"median":-2.154549,"eighty":-0.722119,"marketCap":9072904},{"date":"2023-03-03","current":0.752081,"twenty":-4.104269,"median":-2.149915,"eighty":-0.702453,"marketCap":8936981},{"date":"2023-03-10","current":0.629435,"twenty":-4.033134,"median":-2.136015,"eighty":-0.69852,"marketCap":7479577},{"date":"2023-03-17","current":0.621492,"twenty":-4.001878,"median":-2.108214,"eighty":-0.69616,"marketCap":7385185},{"date":"2023-03-24","current":0.660891,"twenty":-3.965473,"median":-2.07345,"eighty":-0.690654,"marketCap":7853367},{"date":"2023-03-31","current":-0.948348,"twenty":-3.915415,"median":-2.065977,"eighty":-0.688294,"marketCap":7816283},{"date":"2023-04-06","current":-0.959343,"twenty":-3.889599,"median":-2.052815,"eighty":-0.688294,"marketCap":7906907},{"date":"2023-04-14","current":-1.006532,"twenty":-3.827716,"median":-2.025144,"eighty":-0.688294,"marketCap":8295833},{"date":"2023-04-21","current":-1.094952,"twenty":-3.800801,"median":-2.009658,"eighty":-0.688294,"marketCap":9024598},{"date":"2023-04-28","current":-1.035394,"twenty":-3.762866,"median":-1.990699,"eighty":-0.688294,"marketCap":8533720},{"date":"2023-05-05","current":-0.984999,"twenty":-3.721769,"median":-1.979984,"eighty":-0.688294,"marketCap":8118362},{"date":"2023-05-12","current":-1.034936,"twenty":-3.659217,"median":-1.959683,"eighty":-0.688294,"marketCap":8529944},{"date":"2023-05-19","current":1.307824,"twenty":-3.590813,"median":-1.953003,"eighty":-0.62356,"marketCap":8571480},{"date":"2023-05-26","current":1.269223,"twenty":-3.551824,"median":-1.941439,"eighty":-0.593899,"marketCap":8318489},{"date":"2023-06-02","current":1.225437,"twenty":-3.52457,"median":-1.933362,"eighty":-0.561113,"marketCap":8031514},{"date":"2023-06-09","current":1.293997,"twenty":-3.472925,"median":-1.931296,"eighty":-0.53097,"marketCap":8480856},{"date":"2023-06-16","current":1.429965,"twenty":-3.448626,"median":-1.923181,"eighty":-0.522991,"marketCap":9371988},{"date":"2023-06-23","current":1.832106,"twenty":-3.404905,"median":-1.909241,"eighty":-0.488682,"marketCap":12007624},{"date":"2023-06-30","current":1.947333,"twenty":-3.388492,"median":-1.894612,"eighty":-0.479372,"marketCap":12762820},{"date":"2023-07-07","current":1.958856,"twenty":-3.336284,"median":-1.890722,"eighty":-0.461086,"marketCap":12838340},{"date":"2023-07-14","current":2.017045,"twenty":-3.28054,"median":-1.87855,"eighty":-0.435864,"marketCap":13219714},{"date":"2023-07-21","current":2.369063,"twenty":-3.21113,"median":-1.860968,"eighty":-0.410271,"marketCap":15526840},{"date":"2023-07-28","current":2.082724,"twenty":-3.161463,"median":-1.848291,"eighty":-0.373238,"marketCap":13650176},{"date":"2023-08-04","current":2.074083,"twenty":-3.143393,"median":-1.84,"eighty":-0.35976,"marketCap":13593537},{"date":"2023-08-11","current":1.957703,"twenty":-3.125944,"median":-1.827398,"eighty":-0.343256,"marketCap":12830788},{"date":"2023-08-18","current":-0.381172,"twenty":-3.078872,"median":-1.818996,"eighty":-0.332284,"marketCap":18124716},{"date":"2023-08-25","current":-0.415288,"twenty":-3.029373,"median":-1.817905,"eighty":-0.332284,"marketCap":19746943},{"date":"2023-09-01","current":-0.446994,"twenty":-2.989657,"median":-1.810594,"eighty":-0.332284,"marketCap":21254547},{"date":"2023-09-08","current":-0.420639,"twenty":-2.973696,"median":-1.810594,"eighty":-0.332284,"marketCap":20001375},{"date":"2023-09-15","current":-0.445556,"twenty":-2.960128,"median":-1.795851,"eighty":-0.332284,"marketCap":21186192},{"date":"2023-09-22","current":-0.394524,"twenty":-2.933767,"median":-1.789589,"eighty":-0.332284,"marketCap":18759596},{"date":"2023-09-29","current":-0.391329,"twenty":-2.919659,"median":-1.782149,"eighty":-0.332284,"marketCap":18607697},{"date":"2023-10-06","current":-0.343411,"twenty":-2.899577,"median":-1.776987,"eighty":-0.332284,"marketCap":16329203},{"date":"2023-10-13","current":-0.327439,"twenty":-2.883682,"median":-1.764944,"eighty":-0.328321,"marketCap":15569705},{"date":"2023-10-20","current":-0.320251,"twenty":-2.87071,"median":-1.755982,"eighty":-0.319653,"marketCap":15227931},{"date":"2023-10-27","current":-0.430462,"twenty":-2.848433,"median":-1.751781,"eighty":-0.315974,"marketCap":20468466},{"date":"2025-06-17","current":-0.345681,"twenty":-2.587053,"median":-1.08579,"eighty":-0.175718,"marketCap":10192829},{"date":"2025-07-25","current":-2.530939,"twenty":-2.520186,"median":-0.984999,"eighty":-0.169604,"marketCap":180881157},{"date":"2025-08-01","current":-2.414306,"twenty":-2.512378,"median":-0.984999,"eighty":-0.169604,"marketCap":172545620},{"date":"2025-08-08","current":-2.138274,"twenty":-2.502835,"median":-0.984999,"eighty":-0.169604,"marketCap":152818182},{"date":"2025-08-15","current":-2.707833,"twenty":-2.507436,"median":-0.984999,"eighty":-0.169604,"marketCap":193523388},{"date":"2025-08-22","current":-3.939042,"twenty":-2.518451,"median":-0.984999,"eighty":-0.169604,"marketCap":281515449},{"date":"2025-08-29","current":-3.870656,"twenty":-2.533218,"median":-0.984999,"eighty":-0.169604,"marketCap":276628028},{"date":"2025-09-05","current":-3.744825,"twenty":-2.546538,"median":-0.982021,"eighty":-0.169461,"marketCap":267635173},{"date":"2025-09-12","current":-3.432984,"twenty":-2.56751,"median":-0.984999,"eighty":-0.169604,"marketCap":245348534},{"date":"2025-09-19","current":-3.539667,"twenty":-2.58242,"median":-0.984999,"eighty":-0.169604,"marketCap":252972910},{"date":"2025-09-26","current":-3.394688,"twenty":-2.593613,"median":-0.984999,"eighty":-0.169604,"marketCap":242611578},{"date":"2025-10-03","current":-3.290741,"twenty":-2.627618,"median":-0.984999,"eighty":-0.169604,"marketCap":235182698},{"date":"2025-10-10","current":-3.356392,"twenty":-2.661594,"median":-0.984999,"eighty":-0.169604,"marketCap":239874622},{"date":"2025-10-17","current":-3.378276,"twenty":-2.67655,"median":-0.984999,"eighty":-0.169604,"marketCap":241438597},{"date":"2025-10-24","current":-3.498635,"twenty":-2.689355,"median":-0.984999,"eighty":-0.169604,"marketCap":250040458},{"date":"2025-10-31","current":-3.422043,"twenty":-2.698677,"median":-0.984999,"eighty":-0.169604,"marketCap":244566546},{"date":"2025-11-07","current":-3.583434,"twenty":-2.742274,"median":-0.984999,"eighty":-0.169604,"marketCap":256100860},{"date":"2025-11-14","current":-3.5506,"twenty":-2.768258,"median":-0.984999,"eighty":-0.169604,"marketCap":253754301},{"date":"2025-11-21","current":-3.577955,"twenty":-2.801418,"median":-0.984999,"eighty":-0.169604,"marketCap":255709265},{"date":"2025-11-28","current":-4.116836,"twenty":-2.807709,"median":-0.984999,"eighty":-0.169604,"marketCap":294222051},{"date":"2025-12-05","current":-3.553336,"twenty":-2.825536,"median":-0.984999,"eighty":-0.169604,"marketCap":253949797},{"date":"2025-12-12","current":-4.187958,"twenty":-2.846705,"median":-0.984999,"eighty":-0.169604,"marketCap":299304957},{"date":"2025-12-19","current":-3.342707,"twenty":-2.846705,"median":-0.984999,"eighty":-0.169604,"marketCap":238896576},{"date":"2025-12-26","current":-3.383738,"twenty":-2.870518,"median":-0.984999,"eighty":-0.169604,"marketCap":241829022},{"date":"2026-01-02","current":-3.244231,"twenty":-2.887152,"median":-0.984999,"eighty":-0.169604,"marketCap":231858706},{"date":"2026-01-09","current":-3.000777,"twenty":-2.947456,"median":-0.984999,"eighty":-0.169604,"marketCap":214459528}],"updateTime":1768265249656},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBIO\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1182886191","title":"Crescent Biopharma 宣布其PD-1/VEGF双特异性抗体CR-001及靶向ITGB6的ADC药物CR-003新药临床试验申请获监管批准，用于治疗实体瘤","url":"https://stock-news.laohu8.com/highlight/detail?id=1182886191","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182886191?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 20:01","pubTimestamp":1767614506,"startTime":"0","endTime":"0","summary":"Crescent Biopharma Inc 宣布，其两款在研新药——PD-1/VEGF双特异性抗体CR-001，以及靶向整合素β6（ITGB6）的抗体偶联药物（ADC）CR-003——的新药临床试验（IND）申请已获得监管机构批准。这两款候选药物均拟用于实体瘤的治疗，标志着公司在肿瘤免疫治疗领域取得重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK4139"],"gpt_icon":0},{"id":"1158200264","title":"新闻稿：Crescent Biopharma公布诱导奖励授予情况","url":"https://stock-news.laohu8.com/highlight/detail?id=1158200264","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158200264?lang=zh_cn&edition=fundamental","pubTime":"2025-12-19 05:18","pubTimestamp":1766092728,"startTime":"0","endTime":"0","summary":"马萨诸塞州沃尔瑟姆，2025年12月18日-- Crescent Biopharma, Inc.，一家致力于快速推进癌症患者下一波治疗方案的生物技术公司，今天宣布其独立董事会批准向三名非执行员工授予总计129,626股公司普通股的期权作为《Crescent Biopharma, Inc. 2025就业诱导激励奖励计划》下的股权诱导奖励。该期权于2025年12月13日批准，2025年12月15日授予，并且对于每位员工接受Crescent的工作至关重要，符合纳斯达克上市规则5635。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CBIO"],"gpt_icon":0},{"id":"2589834311","title":"BUZZ--美国股票走势-雷蒙德-詹姆斯、CAVA、派拉蒙天空之舞","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834311","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589834311?lang=zh_cn&edition=fundamental","pubTime":"2025-12-05 03:04","pubTimestamp":1764875076,"startTime":"0","endTime":"0","summary":"nL4N3XA0S5 ** MDU Resources Group Inc MDU.N:BUZZ - 因发行 2 亿美元股票而下跌 nL6N3XA0QE ** Toll Brothers Inc TOL.N:BUZZ - 上涨；摩根大通将其评级上调至 \"增持\"。nL6N3XA0O5 ** Beta Technologies Inc BETA.N:BUZZ--第三季度营收增长近三倍后获得收益 nL6N3XA0PS ** NiSource Inc NI.N:BUZZ - 因亚马逊数据中心交易而上调NiSource的PT值 nL4N3XA0W8 ** USA Rare Earth Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4T3XA1GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOL","RJF","BBW","ARE","LU0949170772.SGD","FIVE","KR","GEV","DG","CURV","LEN","PPG","GCO","SCCO","LU1815336760.USD","FCX","LKQ","LU2381873111.SGD","GWRE","V","ULS","HYNE","XYZ","CDE","BETA","DCI","LU1242518931.SGD","HRL","LU2063271972.USD","MA","FISV","NI","SNCR","MDU","AI","HL","PSKY","LU0154236417.USD","CAVA","CVX","AXGN","CBIO"],"gpt_icon":1},{"id":"2589283431","title":"BUZZ--美国股票走势-雷蒙德-詹姆斯、CAVA、派拉蒙天空之舞","url":"https://stock-news.laohu8.com/highlight/detail?id=2589283431","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589283431?lang=zh_cn&edition=fundamental","pubTime":"2025-12-05 03:04","pubTimestamp":1764875076,"startTime":"0","endTime":"0","summary":"nL4N3XA0S5 ** MDU Resources Group Inc MDU.N:BUZZ - 因发行 2 亿美元股票而下跌 nL6N3XA0QE ** Toll Brothers Inc TOL.N:BUZZ - 上涨；摩根大通将其评级上调至 \"增持\"。nL6N3XA0O5 ** Beta Technologies Inc BETA.N:BUZZ--第三季度营收增长近三倍后获得收益 nL6N3XA0PS ** NiSource Inc NI.N:BUZZ - 因亚马逊数据中心交易而上调NiSource的PT值 nL4N3XA0W8 ** USA Rare Earth Inc","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4S3XA1GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FISV","LU0823421416.USD","SNCR","BBW","LEN","CAVA","DG","CURV","HRL","LU2360107168.USD","TOL","XYZ","NI","HYNE","LU2430703251.USD","CVX","HL","GCO","GWRE","PPG","SCCO","CBIO","AXGN","LU0096362180.USD","V","LKQ","ULS","MDU","BETA","AI","KR","CDE","MA","FCX","FIVE","GEV","LU0348723411.USD","DCI","ARE","PSKY","LU2077746001.SGD","RJF"],"gpt_icon":1},{"id":"2588835819","title":"BUZZ--美国股票走势-Meta、GE Vernova、Kroger","url":"https://stock-news.laohu8.com/highlight/detail?id=2588835819","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588835819?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 23:44","pubTimestamp":1764863065,"startTime":"0","endTime":"0","summary":"nL4N3XA0T6 ** PPG Industries Inc PPG.N:BUZZ - 在汽车修补漆销售不确定的情况下，贝伦贝格下调PPG Industries的PT值。nL4N3XA0S5 ** MDU Resources Group Inc MDU.N:BUZZ - 因发行 2 亿美元股票而下跌 nL6N3XA0QE ** Toll Brothers Inc TOL.N:BUZZ - 上涨；摩根大通将其评级上调至 \"增持\"。nL6N3XA0O5 ** Beta Technologies Inc BETA.N:BUZZ--第三季度营收增长近三倍后获得收益 nL6N3XA0PS ** NiSource Inc NI.N:BUZZ - 因亚马逊数据中心交易而上调NiSource的PT值 nL4N3XA0W8 ** USA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4T3XA17K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1363072403.SGD","LU2417539215.USD","AI","META","V","SCCO","PPG","CBIO","CDE","LU2896262040.SGD","ULS","LU2077746001.SGD","GEV","HRL","GCO","LU0368265764.SGD","LU1496350502.SGD","TOL","CURV","FIVE","FISV","LEN","NI","LU0724618789.USD","KR","DG","ARE","LU2506951792.HKD","XYZ","GWRE","BETA","FCX","LU0505663152.USD","HL","DCI","LU0278409577.USD","MDU","AXGN","BBW","LU0265550946.USD","CVX","LU1430594728.SGD","MA"],"gpt_icon":1},{"id":"2588483581","title":"BUZZ--美国股票走势-Meta、GE Vernova、Kroger","url":"https://stock-news.laohu8.com/highlight/detail?id=2588483581","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588483581?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 23:44","pubTimestamp":1764863065,"startTime":"0","endTime":"0","summary":"nL4N3XA0T6 ** PPG Industries Inc PPG.N:BUZZ - 在汽车修补漆销售不确定的情况下，贝伦贝格下调PPG Industries的PT值。nL4N3XA0S5 ** MDU Resources Group Inc MDU.N:BUZZ - 因发行 2 亿美元股票而下跌 nL6N3XA0QE ** Toll Brothers Inc TOL.N:BUZZ - 上涨；摩根大通将其评级上调至 \"增持\"。nL6N3XA0O5 ** Beta Technologies Inc BETA.N:BUZZ--第三季度营收增长近三倍后获得收益 nL6N3XA0PS ** NiSource Inc NI.N:BUZZ - 因亚马逊数据中心交易而上调NiSource的PT值 nL4N3XA0W8 ** USA","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4S3XA17K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEN","LU2505996681.GBP","DCI","V","KR","GEV","MDU","AXGN","IE0034235188.USD","CDE","HRL","XYZ","LU1585245621.USD","LU0788108826.HKD","FISV","LU0320765059.SGD","LU2602419157.SGD","FCX","DG","PPG","CVX","LU0963586101.USD","BBW","AI","IE00BJJMRY28.SGD","BETA","ARE","MA","CBIO","LU1823568750.SGD","HL","META","GWRE","LU2249611893.SGD","FIVE","TOL","NI","GCO","ULS","LU0158827948.USD","LU2065171311.SGD","SCCO","CURV"],"gpt_icon":1},{"id":"2588813678","title":"BUZZ-新月生物制药公司在合作开发抗癌药物后业绩大增","url":"https://stock-news.laohu8.com/highlight/detail?id=2588813678","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588813678?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 20:24","pubTimestamp":1764851059,"startTime":"0","endTime":"0","summary":"BUZZ-新月生物制药公司在合作开发抗癌药物后业绩大增12月4日 - ** 新月生物制药CBIO.O股价盘前上涨36.5%至18.30美元 ** 公司称已与中国科伦生物技术公司建立独家合作伙伴关系，共同开发和销售新型癌症治疗药物** 公司还将向投资者募集 1.85 亿美元，用于资助临床试验 - CBIO** 凯伦生物技术公司获得了该公司实验药物CR-001在大中华区的销售权。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4T3XA0VZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","06990","LU0196878994.USD","BK4139","LU1064130708.USD","LU1064131003.USD","BK7508","LU1934453819.USD","LU1979443071.USD","BK1161","BK7096","CBIO","LU2148510915.USD","BK0060","BK7509","IVX.AU","002422"],"gpt_icon":0},{"id":"1137740447","title":"Crescent Biopharma 宣布与 Kelun-Biotech 达成重大合作，并进行 1.85 亿美元私人配售，推动和扩展全球下一代实体肿瘤治疗药物的管道","url":"https://stock-news.laohu8.com/highlight/detail?id=1137740447","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137740447?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 19:36","pubTimestamp":1764848174,"startTime":"0","endTime":"0","summary":"Crescent Biopharma 宣布与 Kelun-Biotech 达成重大合作，并进行 1.85 亿美元私人配售，推动和扩展全球下一代实体肿瘤治疗药物的管道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CBIO"],"gpt_icon":0},{"id":"1115537632","title":"Crescent Biopharma Inc - 将获得2000万美元的预付款，以及来自科伦博泰生物的最高3000万美元的额外里程碑款项","url":"https://stock-news.laohu8.com/highlight/detail?id=1115537632","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115537632?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 19:32","pubTimestamp":1764847944,"startTime":"0","endTime":"0","summary":"Crescent Biopharma Inc - 将获得2000万美元的预付款，以及来自科伦博泰生物的最高3000万美元的额外里程碑款项","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0060","CBIO","002422","LU1934453819.USD","LU0196878994.USD","LU1064130708.USD","LU2148510915.USD","06990","LU1979443071.USD","BK0239","BK4139","LU1064131003.USD"],"gpt_icon":0},{"id":"1126942018","title":"Crescent Biopharma Inc - 科伦博泰生物-B将获得8000万美元的预付款，以及来自Crescent的最高达12.5亿美元的额外里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=1126942018","media":"美股速递","labels":["shareholding","corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126942018?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 19:32","pubTimestamp":1764847941,"startTime":"0","endTime":"0","summary":"Crescent Biopharma Inc - 科伦博泰生物-B将获得8000万美元的预付款，以及来自Crescent的最高达12.5亿美元的额外里程碑付款","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU1934453819.USD","LU1979443071.USD","LU2148510915.USD","LU1064130708.USD","BK4139","CBIO","BK0060","06990","LU0196878994.USD","002422","BK0239","LU1064131003.USD"],"gpt_icon":0},{"id":"1115079280","title":"科伦药业与Crescent Biopharma达成战略合作，共同开发及商业化新型抗肿瘤疗法","url":"https://stock-news.laohu8.com/highlight/detail?id=1115079280","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115079280?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 19:30","pubTimestamp":1764847815,"startTime":"0","endTime":"0","summary":"科伦药业与Crescent Biopharma达成战略合作，共同开发及商业化新型抗肿瘤疗法","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK0239","BK1161","BK0060","06990","LU1934453819.USD","LU2148510915.USD","002422","LU1064130708.USD","LU1064131003.USD","LU1979443071.USD","BK4139","LU0196878994.USD"],"gpt_icon":0},{"id":"1118946436","title":"Crescent Biopharma：截至9月30日现金为1.333亿美元，预计可支持运营至2027年","url":"https://stock-news.laohu8.com/highlight/detail?id=1118946436","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118946436?lang=zh_cn&edition=fundamental","pubTime":"2025-11-06 20:37","pubTimestamp":1762432661,"startTime":"0","endTime":"0","summary":"Crescent Biopharma：截至9月30日现金为1.333亿美元，预计可支持运营至2027年","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CBIO"],"gpt_icon":0},{"id":"2571337076","title":"凯赛生物拟推2025年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2571337076","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571337076?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 22:11","pubTimestamp":1759155072,"startTime":"0","endTime":"0","summary":"员工持股计划初始设立时持有人总人数不超过155人，其中董事、高级管理人员共6人，具体参加人数根据员工实际缴款情况确定。员工持股计划拟持有的标的股票数量不超过130.00万股，约占员工持股计划草案公布时公司股本总额的0.18%。为满足公司可持续发展的需要及不断吸引和留住优秀人才，员工持股计划拟预留15.00万股作为预留份额，占员工持股计划股票总数的11.54%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929221421a44c8e96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929221421a44c8e96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139"],"gpt_icon":0},{"id":"2571933700","title":"凯赛生物授权子公司互保，额度不超20亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2571933700","media":"格隆汇APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571933700?lang=zh_cn&edition=fundamental","pubTime":"2025-09-29 21:05","pubTimestamp":1759151100,"startTime":"0","endTime":"0","summary":"格隆汇9月29日｜上海凯赛生物技术股份有限公司公告，为满足非全资控股子公司发展和经营需求，授权其在其他非全资控股子公司申请信贷及日常经营时提供担保，授权期内担保发生余额合计不超20亿元，实际金额以合同或批复为准。截至公告日，非全资控股子公司对外担保总额5亿元，均为子公司间担保，无逾期及涉诉担保。主要被担保人包括凯赛（太原）生物材料有限公司、凯赛（太原）生物科技有限公司，二者资产负债率未超70%。本次授权已通过董事会审议，无需股东会审议，担保风险可控，不存在损害公司及股东利益情形。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929221728954c785c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250929221728954c785c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139"],"gpt_icon":0},{"id":"2556055813","title":"新月生物制药公司公布截至 6 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2556055813","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556055813?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 19:59","pubTimestamp":1754049593,"startTime":"0","endTime":"0","summary":"新月生物制药公司公布截至 6 月 30 日的季度业绩 - 收益摘要Crescent Biopharma Inc CBIO.OQ报告，截至6月30日的季度调整后每股亏损4.93美元，高于去年同期的每股收益16.00美元。华尔街预期为每股亏损 4.06 美元至 0 美分。该公司当季亏损 2179 万美元。Crescent Biopharma Inc 的股价本季度下跌了 23.0%，今年迄今为止下跌了 50.1%。)季度末预计 实际超过、达到、未达到6 月 30 日 2025 -1.76-4.93未达到2025 年 3 月 31 日 -5.00-4.00节拍-11.20-26.00(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nL4T3TT13V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBIO","BK4139"],"gpt_icon":0},{"id":"2556889051","title":"凯赛生物：累计回购23万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2556889051","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556889051?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 18:54","pubTimestamp":1754045656,"startTime":"0","endTime":"0","summary":"格隆汇8月1日丨凯赛生物(688065.SH)公布，2025年7月31日，公司通过上海证券交易所交易系统以集中竞价交易方式回购公司股份230,366股,占公司总股本721,289,794股的比例为0.0319%。回购成交的最高价为53.40元/股，最低价为44.08元/股，支付的资金总额为人民币10,497,716.71元（不含印花税、交易佣金等交易费用)。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801185648a46f9b1b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801185648a46f9b1b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CBIO"],"gpt_icon":0},{"id":"2555308574","title":"复利研究院点评凯赛生物：如果合成生物是未来的石油，凯赛能否成为它的中石化？","url":"https://stock-news.laohu8.com/highlight/detail?id=2555308574","media":"全景网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2555308574?lang=zh_cn&edition=fundamental","pubTime":"2025-07-29 10:22","pubTimestamp":1753755720,"startTime":"0","endTime":"0","summary":"本期复利研究院，将带你拆开凯赛生物的底层逻辑：看懂它的菌种、工艺、利润结构、护城河与风险点。研究这样的合成生物龙头企业，不能只看财务数字，也不能套传统消费/医药/材料的框架。凯赛的根是“合成生物技术”+“工业级发酵工程”： 是否具备自主菌种构建能力？合成生物不是纯国产替代，而是全球技术竞争： 凯赛是全球领先的吗？我们现在正式开始对的结构化拆解。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072910232897245b4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072910232897245b4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0010","LU0651946864.USD","BK0015","00386","LU1781817850.SGD","LU1051768304.USD","BK0208","BK0196","BK0025","CBIO","LU1515016050.SGD","BK0176","BK0000","BK0028","BK0012","600028","BK0188","BK0274","688065","LU1580142542.USD","BK0006","BK0183"],"gpt_icon":0},{"id":"2554718876","title":"68倍PE，凯赛生物值不值？","url":"https://stock-news.laohu8.com/highlight/detail?id=2554718876","media":"钛媒体APP","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554718876?lang=zh_cn&edition=fundamental","pubTime":"2025-07-26 09:16","pubTimestamp":1753492573,"startTime":"0","endTime":"0","summary":"问题是，凯赛生物真的值这么高的溢价吗？毛利率为负，直观说明凯赛生物生物基聚酰胺系列产品经营状况不容乐观，销售收入无法覆盖生产成本及相关费用。2025年4月，凯赛生物完成了对招商局的定增事项，募集资金净额为59.14亿元。03 面临诸多挑战目前，凯赛生物在全球生物法长链二元酸领域占据主导地位。概而言之，凯赛生物第二曲线的推进仍内含不确定性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726092027a6c26d2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726092027a6c26d2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CBIO","BK4139","PDI"],"gpt_icon":0},{"id":"2553753954","title":"从业绩和技术看凯赛生物的行业定位：“合成生物第一股”是怎么炼成的？","url":"https://stock-news.laohu8.com/highlight/detail?id=2553753954","media":"市值风云","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553753954?lang=zh_cn&edition=fundamental","pubTime":"2025-07-21 18:10","pubTimestamp":1753092636,"startTime":"0","endTime":"0","summary":"2020年8月，凯赛生物登陆上交所科创板，成为科创板“合成生物第一股”。凯赛生物是全球领先的生物新材料高新企业，这5年来在业绩和市场拓展方面取得了显著进展。多重催化下，聚酰胺业务有望实现爆发凯赛生物的主营产品包括两块：长链二元酸系列、生物基聚酰胺系列。2018、2021年，凯赛生物两次荣获长碳链二元酸制造业“单项冠军”认定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721182156a4593a96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721182156a4593a96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688065","BK0208","CBIO"],"gpt_icon":0},{"id":"1155752159","title":"新月生物制药提交实益所有权初始声明 首席科学官简·平卡斯为申报人","url":"https://stock-news.laohu8.com/highlight/detail?id=1155752159","media":"华尔街洞察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155752159?lang=zh_cn&edition=fundamental","pubTime":"2025-07-16 04:18","pubTimestamp":1752610726,"startTime":"0","endTime":"0","summary":"新月生物制药公司已向美国证券交易委员会提交实益所有权初始声明。根据申报文件披露，公司首席科学官简·平卡斯被确认为实益所有权人。该文件完整版本可通过下方链接获取。根据美国证监会规定，上市公司高管及持股超5%的股东需通过特定表格披露实益所有权变动。此次申报标志着平卡斯作为新任高管首次完成法定披露程序。作为生物医药企业的核心科研负责人，其持股动向通常受到投资者关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","CBIO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}